PAHC (Phibro Animal Health) Cyclically Adjusted Revenue per Share: $27.80 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAHC Phibro Animal Health Corp PAHC
75 GF Score
Price $34.26
GF Value $29.54
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Phibro Animal Health Cyclically Adjusted Revenue per Share?

Phibro Animal Health PAHC -3.41% 75 Cyclically Adjusted Revenue per Share is $27.80 as of Mar. 2026. GuruFocus rates PAHC with a GF Score™ of 75/100 and a GF Value™ of $29.54 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Phibro Animal Health's adjusted revenue per share for the three months ended in Mar. 2026 was $9.346. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $27.80 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Phibro Animal Health's average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Phibro Animal Health was 2.90% per year. The lowest was 2.90% per year. And the median was 2.90% per year.

As of today (2026-08-08), Phibro Animal Health's current stock price is $34.26. Phibro Animal Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $27.80. Phibro Animal Health's Cyclically Adjusted PS Ratio of today is 1.23.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Phibro Animal Health was 2.08. The lowest was 0.39. And the median was 0.75.


Phibro Animal Health  (NAS:PAHC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Phibro Animal Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=34.26/27.80
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Phibro Animal Health was 2.08. The lowest was 0.39. And the median was 0.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Phibro Animal Health Cyclically Adjusted Revenue per Share Related Terms


Phibro Animal Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Phibro Animal Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Cyclically Adjusted Revenue per Share Chart

Phibro Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 24.19 24.63 25.03 26.36

Phibro Animal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.84 26.36 26.80 26.99 27.80

PAHC vs PRGO, HROW, XERS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Cyclically Adjusted PS Ratio falls into.


PAHC
75GF Score
Phibro Animal Health Corp PAHC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phibro Animal Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Phibro Animal Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.346/330.2130*330.2130
=9.346

Current CPI (Mar. 2026) = 330.2130.

Phibro Animal Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.746 241.018 6.502
201609 4.711 241.428 6.443
201612 4.790 241.432 6.551
201703 4.740 243.801 6.420
201706 4.846 244.955 6.533
201709 4.800 246.819 6.422
201712 5.100 246.524 6.831
201803 5.172 249.554 6.844
201806 5.230 251.989 6.854
201809 4.935 252.439 6.455
201812 5.385 251.233 7.078
201903 5.076 254.202 6.594
201906 5.030 256.143 6.485
201909 4.684 256.759 6.024
201912 5.284 256.974 6.790
202003 5.203 258.115 6.656
202006 4.589 257.797 5.878
202009 4.819 260.280 6.114
202012 5.090 260.474 6.453
202103 5.227 264.877 6.516
202106 5.438 271.696 6.609
202109 5.300 274.310 6.380
202112 5.745 278.802 6.804
202203 5.916 287.504 6.795
202206 6.302 296.311 7.023
202209 5.741 296.808 6.387
202212 6.040 296.797 6.720
202303 6.065 301.836 6.635
202306 6.297 305.109 6.815
202309 5.712 307.789 6.128
202312 6.171 306.746 6.643
202403 6.496 312.332 6.868
202406 6.734 314.175 7.078
202409 6.417 315.301 6.720
202412 7.596 315.605 7.948
202503 8.544 319.799 8.822
202506 9.303 322.561 9.524
202509 8.902 324.800 9.050
202512 9.130 324.054 9.304
202603 9.346 330.213 9.346

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $27.80 mean?
Phibro Animal Health (PAHC) has a Cyclically Adjusted Revenue per Share of $27.80 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Phibro Animal Health and its competitors.
Is Phibro Animal Health's Cyclically Adjusted Revenue per Share too high?
Phibro Animal Health's current Cyclically Adjusted Revenue per Share is $27.80. Overall, Phibro Animal Health has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Cyclically Adjusted Revenue per Share compare to PRGO and HROW?
Phibro Animal Health's Cyclically Adjusted Revenue per Share of $27.80 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Phibro Animal Health and its competitors. Phibro Animal Health's current Cyclically Adjusted Revenue per Share is $27.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $29.54, compared to a current price of $34.26 — trading 16% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $27.80. Phibro Animal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current Cyclically Adjusted Revenue per Share is $27.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phibro Animal Health (PAHC) Overvalued in 2026?

Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued. The current stock price of $34.26 is trading 16% above its estimated GF Value™ of $29.54. GuruFocus considers Phibro Animal Health to be Modestly Overvalued.

Key valuation signals for PAHC:

  • Cyclically Adjusted Revenue per Share: $27.80
  • GF Value™: $29.54 vs. price of $34.26 (16% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phibro Animal Health Business Description

Other Exchanges PB8:Germany
Address 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
75GF Score

Get the complete analysis for PAHC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.26
Price
$29.54
GF Value